Ferring Pharmaceuticals

Activity by year

201820192020202120222023202420252026

InvestmentNew facility

Feb 14, 2018INVESTMENTSaint-Prex, Switzerland, Switzerland$32.0M
Ferring to invest CHF 30M in new biotech centre at Saint-Prex, Switzerland
Ferring Pharmaceuticals will invest approximately 30 million CHF over three years to build a new Ferring Biotech Centre at its existing headquarters and manufacturing site in Saint-Prex, Switzerland. The centre will include discovery, development and manufacturing capabilities for biologics and monoclonal antibodies.
Ferring Pharmaceuticals #Medical Devices ferring.com
Feb 1, 2018NEW FACILITYSaint-Prex, Switzerland$32.1Mops 2019
Ferring Pharmaceuticals to build biotechnology centre in Saint-Prex
Swiss biopharmaceutical company Ferring Pharmaceuticals announced plans to build a biotechnology centre at its headquarters in Saint-Prex, Switzerland, with an investment of more than CHF30m ($32.06m) over three years. The centre will develop biologic drugs and manufacture APIs for Rekovelle.
Ferring Pharmaceuticals #Medical Devices pharmaceutical-technology.com

Site	Largest	Latest
Saint-Prex, Switzerland	$32.1M	2018-02-14

Loading…